Process View
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cell migration involved in sprouting angiogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| JAG1 | jagged 1 | 1.000 | Human | |
| VEGFA | vascular endothelial growth factor A | 1.000 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.999 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.999 | ||
| NOTCH1 | notch 1 | 0.999 | ||
| EGR1 | early growth response 1 | 0.995 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.992 | Mouse | |
| NOTCH3 | notch 3 | 0.937 | Human | |
| KLF4 | Kruppel-like factor 4 (gut) | 0.936 | ||
| NRP1 | neuropilin 1 | 0.936 | Mouse | |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.924 | ||
| EGR3 | early growth response 3 | 0.889 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.885 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.882 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.867 | Human | |
| ENG | endoglin | 0.865 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.859 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.817 | Mouse | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.815 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.811 | Human | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.723 | ||
| EGR2 | early growth response 2 | 0.696 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.678 | Human | |
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.652 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.650 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.637 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.589 | ||
| JUN | jun proto-oncogene | 0.572 | ||
| IER2 | immediate early response 2 | 0.515 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.482 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.456 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.420 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.381 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.364 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.356 | ||
| MEF2C | myocyte enhancer factor 2C | 0.337 | ||
| EFNA1 | ephrin-A1 | 0.314 | ||
| CD247 | CD247 molecule | 0.279 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.271 | ||
| EFNA5 | ephrin-A5 | 0.261 | Human | |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.242 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.239 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.228 | ||
| CTGF | connective tissue growth factor | 0.226 | ||
| FN1 | fibronectin 1 | 0.216 | Zebrafish | |
| HSPG2 | heparan sulfate proteoglycan 2 | 0.209 | ||
| EPHA7 | EPH receptor A7 | 0.201 | Human | |
| DLL1 | delta-like 1 (Drosophila) | 0.200 | Human | |
| KLF6 | Kruppel-like factor 6 | 0.195 | Human | |
| ATF3 | activating transcription factor 3 | 0.194 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.175 | Zebrafish | |
| THBS1 | thrombospondin 1 | 0.157 | ||
| FGF10 | fibroblast growth factor 10 | 0.154 | Human | |
| LAT | linker for activation of T cells | 0.148 | ||
| FGF7 | fibroblast growth factor 7 | 0.147 | Human | |
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.144 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.137 | ||
| FBLN1 | fibulin 1 | 0.133 | ||
| FOSL2 | FOS-like antigen 2 | 0.130 | ||
| FHL2 | four and a half LIM domains 2 | 0.125 | ||
| JAG2 | jagged 2 | 0.122 | Human | |
| MAPK7 | mitogen-activated protein kinase 7 | 0.117 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.103 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.100 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.097 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.097 | ||
| NOTCH2 | notch 2 | 0.096 | Human | |
| PGF | placental growth factor | 0.087 | Human | |
| EGFR | epidermal growth factor receptor | 0.087 | ||
| FLNA | filamin A, alpha | 0.086 | ||
| PXN | paxillin | 0.084 | ||
| JUNB | jun B proto-oncogene | 0.079 | ||
| CPE | carboxypeptidase E | 0.076 | ||
| ZNF746 | zinc finger protein 746 | 0.075 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.072 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.071 | ||
| HDAC4 | histone deacetylase 4 | 0.071 | Human | |
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.065 | ||
| EFNB2 | ephrin-B2 | 0.065 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.061 | Human | |
| PDGFC | platelet derived growth factor C | 0.061 | ||
| ITGA6 | integrin, alpha 6 | 0.061 | ||
| NCK2 | NCK adaptor protein 2 | 0.060 | ||
| ATN1 | atrophin 1 | 0.058 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.057 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.056 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.056 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.055 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.054 | ||
| FOXP3 | forkhead box P3 | 0.053 | ||
| EMP1 | epithelial membrane protein 1 | 0.052 | ||
| GDF9 | growth differentiation factor 9 | 0.048 | ||
| BTG2 | BTG family, member 2 | 0.048 | ||
| ZNF331 | zinc finger protein 331 | 0.047 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.047 | ||
| MYOCD | myocardin | 0.046 | ||
| EPHA3 | EPH receptor A3 | 0.042 | Human | |
| MAML1 | mastermind-like 1 (Drosophila) | 0.041 | ||
| VEGFC | vascular endothelial growth factor C | 0.041 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.041 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.040 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.040 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.039 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.038 | ||
| NRP2 | neuropilin 2 | 0.037 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.037 | ||
| RHOB | ras homolog gene family, member B | 0.036 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.036 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.036 | ||
| SIK1 | salt-inducible kinase 1 | 0.035 | ||
| LDLR | low density lipoprotein receptor | 0.035 | ||
| TLN1 | talin 1 | 0.035 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.035 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.033 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.033 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.032 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.032 | ||
| PGR | progesterone receptor | 0.032 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.031 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.031 | ||
| ASRGL1 | asparaginase like 1 | 0.031 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.030 | ||
| EPHB3 | EPH receptor B3 | 0.030 | Human | |
| COL1A1 | collagen, type I, alpha 1 | 0.030 | ||
| STC1 | stanniocalcin 1 | 0.029 | ||
| CD63 | CD63 molecule | 0.029 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.028 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.027 | ||
| IRS2 | insulin receptor substrate 2 | 0.027 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.026 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.026 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.025 | ||
| TNC | tenascin C | 0.025 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.025 | ||
| MYOG | myogenin (myogenic factor 4) | 0.025 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.025 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.025 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.024 | ||
| MEF2A | myocyte enhancer factor 2A | 0.023 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.023 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.023 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.023 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.023 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.022 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.022 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.022 | ||
| HDAC3 | histone deacetylase 3 | 0.022 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.022 | ||
| ANXA1 | annexin A1 | 0.021 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.021 | ||
| VCL | vinculin | 0.021 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.021 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.020 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.020 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.019 | ||
| THBD | thrombomodulin | 0.019 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.019 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.019 | ||
| NOTCH4 | notch 4 | 0.019 | Human | |
| KLF2 | Kruppel-like factor 2 (lung) | 0.018 | Human | |
| DCN | decorin | 0.018 | ||
| CD9 | CD9 molecule | 0.018 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.018 | ||
| CD34 | CD34 molecule | 0.018 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.018 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.018 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.018 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.018 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.018 | ||
| EPHB2 | EPH receptor B2 | 0.017 | Human | |
| STX5 | syntaxin 5 | 0.017 | ||
| PRKD2 | protein kinase D2 | 0.017 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.017 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.017 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.017 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.017 | ||
| BMP4 | bone morphogenetic protein 4 | 0.016 | ||
| NOV | nephroblastoma overexpressed gene | 0.016 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.016 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.016 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.016 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.016 | ||
| BAD | BCL2-associated agonist of cell death | 0.016 | ||
| EPHA4 | EPH receptor A4 | 0.016 | Human | |
| COL1A2 | collagen, type I, alpha 2 | 0.016 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.016 | ||
| AES | amino-terminal enhancer of split | 0.015 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.015 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.015 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.015 | ||
| EDN1 | endothelin 1 | 0.015 | ||
| GATA2 | GATA binding protein 2 | 0.015 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.015 | ||
| MMP19 | matrix metallopeptidase 19 | 0.015 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.014 | ||
| EMCN | endomucin | 0.014 | ||
| MKL2 | MKL/myocardin-like 2 | 0.014 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.014 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.014 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.014 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.014 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.013 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.013 | ||
| ILK | integrin-linked kinase | 0.013 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.013 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.013 | ||
| LAMA4 | laminin, alpha 4 | 0.013 | ||
| HAS2 | hyaluronan synthase 2 | 0.013 | ||
| TRAF7 | TNF receptor-associated factor 7 | 0.013 | ||
| MYOD1 | myogenic differentiation 1 | 0.012 | ||
| CD83 | CD83 molecule | 0.012 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.012 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.012 | Rat | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.012 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.012 | ||
| PCDH9 | protocadherin 9 | 0.012 | ||
| RND3 | Rho family GTPase 3 | 0.012 | ||
| SYN2 | synapsin II | 0.012 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.012 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.012 | ||
| ZNF71 | zinc finger protein 71 | 0.012 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.012 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.012 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.012 | ||
| ANGPT1 | angiopoietin 1 | 0.012 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.012 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.012 | ||
| FOXF1 | forkhead box F1 | 0.012 | ||
| BMP2 | bone morphogenetic protein 2 | 0.012 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.011 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | Zebrafish | |
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.011 | ||
| CTBP1 | C-terminal binding protein 1 | 0.011 | ||
| FGFBP1 | fibroblast growth factor binding protein 1 | 0.011 | ||
| PER1 | period homolog 1 (Drosophila) | 0.011 | ||
| AHNAK | AHNAK nucleoprotein | 0.011 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.011 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.011 | ||
| EPHB4 | EPH receptor B4 | 0.011 | ||
| TSC2 | tuberous sclerosis 2 | 0.011 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.011 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.011 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.011 | Human | |
| TSC22D3 | TSC22 domain family, member 3 | 0.011 | ||
| ITGA8 | integrin, alpha 8 | 0.010 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.010 | ||
| KLF9 | Kruppel-like factor 9 | 0.010 | ||
| DLL4 | delta-like 4 (Drosophila) | 0.010 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.010 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.010 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.010 | ||
| PRRX1 | paired related homeobox 1 | 0.010 | ||
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.010 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.010 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.010 |